Sitravatinib

Vendor: Abmole

Type: Molecular

SKU: M9626

Explore specifications & documents
$103.50 USD
Shipping calculated at checkout.

Documents

Coa

Available in stock (500)

Request a quotation
  • Customs clearance fees may apply
  • Worldwide shipping available.
For research use only — not intended for clinical or diagnostic purposes.
Sitravatinib

Sitravatinib

$103.50 USD

THE SCIENCE, IN DETAIL

Know your product.

Specifications
Bioactivity
Sitravatinib (MGCD516) is an orally active receptor tyrosine kinase (RTK) inhibitor. Inhibition of Axl, MER, VEGFR3, VEGFR2, VEGFR1, KIT, FLT3, DDR2, DDR1, TRKA, and TRKB at 1.5 nM, 2 nM, 2 nM, 5 nM, 6 nM, 6 nM, 8 nM, 0.5 nM, respectively. 29 nM, 5 nM and 9 nM. Sitravatinib alone has a potent antitumor effect and enhances pD-1 blockade activity by promoting the antitumor immune microenvironment.
Casnumber
1123837-84-2
Formula
C33H29F2N5O4S
Mw
629.68
Psmiles
COCCNCC1=CC=C(N=C1)C2=CC3=C(S2)C(=CC=N3)OC4=CC=C(NC(=O)C5(CC5)C(=O)NC6=CC=C(F)C=C6)C=C4F
Purity
100.0%
Solubility
DMSO ≥ 26 mg/mL
Target synonyms
MGCD516; MG516
Technical documents

Documents

Coa

A PARTNER IN YOUR RESEARCH

More time for discovery. Less time sourcing.

Bring your laboratory requirements together with scientific advice, global sourcing and dedicated procurement support.

Explore our services

Starting a new laboratory?

Plan your laboratory with our New-Lab programme.

Discover New-Lab